For non-exempt studies, the IRB must review and approve all recruitment materials (e.g., emails, flyers, social media ads, radio/newspaper ads etc.), and approve them before they are used.  The research plan should also describe recruitment strategies that will be used (see the UO Research Plan Guidance). 

If advertising for participants, investigators must follow these guidelines:

• Information must be clear and accurate. Be careful not to use language that could be misleading to subjects, especially when a study will involve vulnerable populations.
• Include the name and address of the investigator, the purpose of the research and eligibility criteria for participation as subjects, a clear description of any benefits and/or risks of participating, the affiliation of the researcher, the location of the research, and whom to contact for further information
• If a drug, device and/or novel procedure/product is being studied in the research and the impact of it is still being evaluated, no claim should be made as to its superiority, safety or effectiveness. Avoid terms such as treatment or therapy when referring to investigational products that are not known to cure, mitigate, treat or prevent their disease/condition (see definition of therapeutic misconception in the HSR Definitions)
• Avoid overemphasis on payments (e.g., not larger/bold font than other text, no details about payments without any context about what the study will entail and/or the time commitment needed for participation)

• A copy of all recruitment materials must be included in the Research Administration Portal (RAP) for all non-exempt studies.